— Know what they know.
Not Investment Advice

TNXP NASDAQ

Tonix Pharmaceuticals Holding Corp.
1W: -0.6% 1M: +6.8% 3M: -0.3% YTD: -15.4% 1Y: -53.2% 3Y: -99.8% 5Y: -100.0%
$12.77
-1.23 (-8.79%)
 
Weekly Expected Move ±11.3%
$12 $14 $16 $18 $19
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 59 · $203.6M mcap · 16M float · 2.64% daily turnover · Short 60% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
47.0 / 100
NoneWeakNarrowWide
Primary source: Switching Costs  ·  ROIC: -307.7%  ·  5Y Avg: -2887.3%
Cost Advantage
38
Intangibles
48
Switching Cost
73
Network Effect
39
Scale
22
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. TNXP shows a Weak competitive edge (47.0/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Switching Costs. Negative ROIC of -307.7% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
Analyst Recommendations
Strong Buy: 0Buy: 6Hold: 1Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$—
Analysts0

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B-
May 22, 2026
DCF
4
ROE
1
ROA
1
D/E
4
P/E
1
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. TNXP receives an overall rating of B-. Strongest factors: DCF (4/5), D/E (4/5), P/B (4/5). Areas of concern: ROE (1/5), ROA (1/5), P/E (1/5).
Rating Change History
DateFromTo
2026-05-11 B B-
2026-05-06 B- B
2026-03-13 C B-
2026-03-12 B C
2026-01-03 B- B

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

30 Grade D
Profitability
20
Balance Sheet
85
Earnings Quality
38
Growth
62
Value
41
Momentum
58
Safety
0
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. TNXP scores highest in Balance Sheet (85/100) and lowest in Safety (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-1.65
Distress Zone
Piotroski F-Score
6/9
Beneish M-Score
-1.55
Possible Manipulator
Ohlson O-Score
-0.80
Bankruptcy prob: 31.1%
Moderate
Credit Rating
BB
Score: 43.7/100
Trend: Stable
Earnings Quality
OCF/NI: 0.85x
Accruals: -9.9%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. TNXP scores -1.65, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. TNXP scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. TNXP's score of -1.55 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. TNXP's implied 31.1% bankruptcy probability is elevated and warrants attention to the balance sheet. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. TNXP receives an estimated rating of BB (score: 43.7/100), with a stable trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-1.19x
PEG
-0.01x
P/S
11.60x
P/B
0.77x
P/FCF
-1.42x
P/OCF
EV/EBITDA
0.12x
EV/Revenue
-1.02x
EV/EBIT
0.12x
EV/FCF
0.13x
Earnings Yield
-78.20%
FCF Yield
-70.38%
Shareholder Yield
5.82%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. TNXP currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
0.982
EBT / EBIT
×
EBIT Margin
-8.551
EBIT / Rev
×
Asset Turnover
0.080
Rev / Assets
×
Equity Multiplier
1.144
Assets / Equity
=
ROE
-76.6%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. TNXP's ROE of -76.6% is driven by Asset Turnover (0.080), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$12.77
Median 1Y
$0.71
5th Pctile
$0.06
95th Pctile
$8.66
Ann. Volatility
142.5%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Seth Lederman
Chief Executive Officer
$702,000 $— $3,168,830
Jessica Morris
Chief Operations Officer
$522,912 $— $1,226,269
Gregory Sullivan
Chief Medical Officer
$519,168 $— $1,216,542
Bradley Saenger
Chief Financial Officer
$502,944 $— $1,143,513

CEO Pay Ratio

3:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $3,168,830
Avg Employee Cost (SGA/emp): $1,252,629
Employees: 70

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
70
-13.6% YoY
Revenue / Employee
$187,243
Rev: $13,107,000
Profit / Employee
$-1,771,729
NI: $-124,021,000
SGA / Employee
$1,252,629
Avg labor cost proxy
R&D / Employee
$635,514
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -1.5% -1.6% -60.2% -64.0% -63.7% -70.6% -51.8% -54.9% -57.3% -56.8% -74.6% -63.1% -95.3% -86.5% -1.1% -1.1% -66.4% -81.0% -64.5% -76.6% -76.62%
ROA -1.3% -1.4% -54.4% -57.8% -57.6% -63.8% -47.2% -50.1% -52.3% -51.9% -61.4% -51.9% -78.4% -71.2% -82.0% -83.1% -51.3% -62.5% -56.4% -67.0% -66.98%
ROIC -4.9% -5.3% -1.8% -1.9% -1.9% -2.1% -1.0% -1.1% -1.1% -1.1% -1.0% -92.5% -83.2% -72.2% -1.3% -1.2% -1.4% -1.7% -2.6% -3.1% -3.08%
ROCE -83.0% -90.4% -42.1% -44.7% -44.6% -49.7% -54.0% -57.6% -60.3% -59.6% -87.3% -78.1% -70.2% -60.9% -53.5% -50.4% -57.3% -68.6% -50.9% -60.9% -60.95%
Gross Margin 40.5% -2.1% 33.1% -52.5% 44.9% 54.2% 61.2% -63.8% 58.4% 71.3% 69.0% 68.99%
Operating Margin -7.1% -7.2% -8.6% -8.3% -5.5% -8.7% -6.6% -14.2% -10.1% -9.0% -6.0% -6.04%
Net Margin -7.0% -7.2% -6.0% -35.7% -5.0% -8.6% -6.9% -14.2% -9.7% -8.7% -5.8% -5.84%
EBITDA Margin -6.8% -6.8% -8.1% -7.8% -5.3% -8.4% -6.7% -13.9% -9.6% -8.9% -6.0% -5.96%
FCF Margin -28.6% -14.1% -8.9% -6.1% -6.1% -6.0% -6.0% -6.9% -7.6% -8.0% -7.6% -7.56%
OCF Margin -25.6% -13.1% -8.5% -5.9% -6.1% -6.0% -6.0% -6.6% -7.3% -7.6% -7.2% -7.15%
ROE 3Y Avg snapshot only -82.69%
ROE 5Y Avg snapshot only -69.86%
ROA 3Y Avg snapshot only -66.00%
ROIC Economic snapshot only -48.53%
Cash ROA snapshot only -45.31%
Cash ROIC snapshot only -3.23%
CROIC snapshot only -3.42%
NOPAT Margin snapshot only -6.80%
Pretax Margin snapshot only -8.40%
R&D / Revenue snapshot only 3.15%
SGA / Revenue snapshot only 3.60%
SBC / Revenue snapshot only 28.65%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -50856.52 -2.76 -17488.54 -12256.72 -362.55 -211.37 -217.08 -324.78 -238.69 -104.37 -20.25 -15.26 -1.91 -0.68 -0.57 -0.80 -3.24 -2.17 -1.07 -1.28 -1.188
P/S Ratio 3166.18 304.09 146.76 22.87 8.17 7.40 10.55 26.82 20.93 10.14 10.74 11.595
P/B Ratio 42483.13 2.51 7379.24 5494.70 161.85 104.46 115.48 183.10 140.58 60.96 22.38 14.26 2.70 0.87 0.53 0.76 1.89 1.54 0.54 0.77 0.771
P/FCF -46632.54 -2.71 -14558.06 -8549.73 -227.44 -136.57 -163.65 -288.16 -240.21 -110.70 -21.49 -16.55 -3.77 -1.33 -1.22 -1.77 -3.91 -2.75 -1.26 -1.42 -1.421
P/OCF
EV/EBITDA -50803.44 -1.81 -17491.36 -12273.19 -360.93 -209.13 -214.78 -321.91 -237.13 -104.12 -20.57 -14.71 -2.99 -0.99 0.25 -0.18 -2.11 -1.25 0.59 0.12 0.121
EV/Revenue 3136.23 302.14 145.29 21.65 6.83 -1.87 1.25 17.31 11.86 -5.60 -1.02 -1.017
EV/EBIT -50784.04 -1.81 -17481.88 -12259.79 -360.18 -208.28 -212.38 -316.30 -231.63 -101.07 -19.83 -14.07 -2.83 -0.93 0.24 -0.17 -2.06 -1.23 0.59 0.12 0.119
EV/FCF -46631.59 -1.78 -14556.46 -8548.46 -226.30 -135.51 -162.83 -287.25 -239.22 -109.65 -21.36 -16.39 -3.57 -1.11 0.31 -0.21 -2.52 -1.56 0.70 0.13 0.135
Earnings Yield -0.0% -36.2% -0.0% -0.0% -0.3% -0.5% -0.5% -0.3% -0.4% -1.0% -4.9% -6.6% -52.3% -1.5% -1.7% -1.2% -30.9% -46.0% -93.3% -78.2% -78.20%
FCF Yield -0.0% -36.9% -0.0% -0.0% -0.4% -0.7% -0.6% -0.3% -0.4% -0.9% -4.7% -6.0% -26.5% -75.0% -81.8% -56.6% -25.6% -36.3% -79.1% -70.4% -70.38%
Price/Tangible Book snapshot only 0.769
EV/Gross Profit snapshot only -1.933
Shareholder Yield snapshot only 5.82%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 8.96 8.96 8.71 8.71 8.71 8.71 7.19 7.19 7.19 7.19 2.53 2.53 2.53 2.53 6.50 6.50 6.50 6.50 7.42 7.42 7.422
Quick Ratio 8.96 8.96 8.71 8.71 8.71 8.71 7.19 7.19 7.19 7.19 1.78 1.78 1.78 1.78 6.04 6.04 6.04 6.04 7.23 7.23 7.227
Debt/Equity 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.09 0.09 0.09 0.09 0.04 0.04 0.04 0.04 0.01 0.01 0.005
Net Debt/Equity -0.86 -0.86 -0.81 -0.81 -0.81 -0.81 -0.58 -0.58 -0.58 -0.58 -0.14 -0.14 -0.14 -0.14 -0.67 -0.67 -0.67 -0.67 -0.84 -0.84 -0.842
Debt/Assets 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.06 0.06 0.06 0.06 0.03 0.03 0.03 0.03 0.00 0.00 0.005
Debt/EBITDA -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.09 -0.10 -0.11 -0.13 -0.07 -0.08 -0.07 -0.05 -0.01 -0.01 -0.009
Net Debt/EBITDA 1.03 0.95 1.93 1.82 1.82 1.64 1.08 1.02 0.98 0.99 0.13 0.15 0.17 0.19 1.26 1.33 1.16 0.96 1.67 1.39 1.393
Interest Coverage
Equity Multiplier 1.12 1.12 1.10 1.10 1.10 1.10 1.09 1.09 1.09 1.09 1.46 1.46 1.46 1.46 1.17 1.17 1.17 1.17 1.13 1.13 1.131
Cash Ratio snapshot only 6.733
Cash to Debt snapshot only 158.623
FCF to Debt snapshot only -101.337
Defensive Interval snapshot only 494.6 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.04 0.05 0.07 0.06 0.06 0.06 0.06 0.06 0.06 0.08 0.080
Inventory Turnover 0.88 1.12 1.59 1.48 0.69 0.62 0.62 0.60 0.99 1.15 1.154
Receivables Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.51 1.23 1.62 1.97 1.79 2.44 2.43 2.38 2.49 1.95 2.61 2.613
Payables Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.22 1.05 1.33 1.90 1.76 1.86 1.69 1.67 1.62 1.13 1.31 1.314
DSO 721 297 225 185 204 150 150 154 147 187 140 139.7 days
DIO 0 414 327 229 247 530 584 592 608 369 316 316.4 days
DPO 1641 347 274 192 207 196 216 219 225 324 278 277.8 days
Cash Conversion Cycle -920 364 278 222 244 484 519 527 530 232 178 178.3 days
Fixed Asset Turnover snapshot only 0.382
Operating Cycle snapshot only 456.1 days
Cash Velocity snapshot only 0.085
Capital Intensity snapshot only 15.788
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 1.0% 1.0% 1.8% 29.9% -2.0% -21.1% -8.8% 29.8% 74.8% 74.84%
Net Income -80.9% -78.7% -82.9% -53.6% -33.4% -35.5% -19.4% -19.1% -25.0% -12.0% -5.8% 15.6% -22.1% -11.8% -11.5% -33.8% 45.4% 26.6% 4.6% -11.7% -11.72%
EPS 66.4% -6203.1% 33.6% 14.7% -5.2% 100.0% -1.7% -2.0% 75.7% 66.9% -77.3% -7.2% -72.2% -30.3% 9.8% 42.9% 69.5% 48.9% 74.6% 51.7% 51.69%
FCF -1.4% -78.9% -94.1% -1.0% -94.9% -1.1% -31.9% 6.3% 22.1% 31.8% 24.8% 31.0% 37.7% 39.4% 44.5% 34.0% 10.8% -13.2% -72.4% -1.2% -1.21%
EBITDA -92.4% -89.2% -82.8% -53.2% -33.1% -35.8% -20.1% -20.0% -25.3% -10.8% -2.9% 13.8% 26.2% 34.9% 35.2% 30.7% 10.5% -24.5% -67.0% -1.1% -1.11%
Op. Income -92.4% -89.1% -82.8% -53.3% -33.4% -36.3% -21.4% -22.0% -28.1% -13.7% -5.6% 11.5% 24.0% 33.3% 34.3% 31.5% 13.4% -21.0% -61.7% -1.1% -1.09%
OCF Growth snapshot only -1.10%
Asset Growth snapshot only 70.16%
Equity Growth snapshot only 75.66%
Debt Growth snapshot only -75.30%
Shares Change snapshot only 1.31%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y
Revenue 5Y
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y
Gross Profit 5Y
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 54.2% 54.2% 1.1% 1.1% 1.1% 1.1% 1.5% 1.5% 1.5% 1.5% 16.3% 16.3% 16.3% 16.3% -12.2% -12.2% -12.2% -12.2% 7.1% 7.1% 7.09%
Assets 5Y 15.9% 15.9% 54.3% 54.3% 54.3% 54.3% 53.2% 53.2% 53.2% 53.2% 42.5% 42.5% 42.5% 42.5% 62.1% 62.1% 62.1% 62.1% 23.1% 23.1% 23.07%
Equity 3Y 52.7% 52.7% 1.1% 1.1% 1.1% 1.1% 1.8% 1.8% 1.8% 1.8% 6.4% 6.4% 6.4% 6.4% -13.9% -13.9% -13.9% -13.9% 5.8% 5.8% 5.77%
Book Value 3Y -90.4% 1.2% -81.3% -77.9% -56.6% -52.6% -1.5% 37.0% 55.0% 82.1% 18.9% 29.3% 15.6% -95.2% 25.7% -4.2% -54.0% -46.5% -24.7% -34.8% -34.81%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.12 0.12 0.00 0.00 0.00 0.00 0.05 0.05 0.05 0.41 0.41 0.41 0.41 0.61 0.68 0.65 0.59 0.78 0.86 0.83 0.825
Earnings Stability 0.21 0.39 0.55 0.72 0.84 0.87 0.89 0.92 0.95 0.96 0.94 0.84 0.99 0.97 0.93 0.83 0.41 0.56 0.79 0.83 0.829
Margin Stability 0.36 0.52 0.56 0.559
Rev. Growth Consistency 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 0.00 0.00 0.00 1.00 0.50 0.500
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.50 0.50 0.50 0.87 0.86 0.92 0.92 0.90 0.95 0.98 0.94 0.91 0.95 0.95 0.86 0.82 0.89 0.98 0.95 0.953
Earnings Smoothness
ROE Trend 1.91 2.11 1.52 1.62 2.12 2.33 -0.03 0.02 0.05 0.12 -0.63 -0.43 -0.89 -0.74 -0.11 -0.20 0.42 0.22 0.51 0.34 0.339
Gross Margin Trend 0.10 0.24 0.26 0.262
FCF Margin Trend 9.76 2.07 -0.14 -0.138
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.95 0.84 0.82 0.87 0.90 0.91 0.89 0.86 0.84 0.84 0.87 0.88 0.49 0.51 0.47 0.45 0.80 0.75 0.81 0.85 0.852
FCF/OCF 1.15 1.21 1.47 1.64 1.78 1.70 1.49 1.32 1.19 1.12 1.08 1.05 1.03 1.01 1.00 1.00 1.04 1.05 1.05 1.06 1.056
FCF/Net Income snapshot only 0.900
CapEx/Revenue 3.0% 1.0% 41.0% 18.9% 4.9% 1.2% 0.2% 26.0% 34.1% 41.1% 40.3% 40.25%
CapEx/Depreciation snapshot only 3.557
Accruals Ratio -0.07 -0.23 -0.10 -0.07 -0.06 -0.06 -0.05 -0.07 -0.09 -0.08 -0.08 -0.06 -0.40 -0.35 -0.44 -0.45 -0.10 -0.15 -0.11 -0.10 -0.099
Sloan Accruals snapshot only 0.433
Cash Flow Adequacy snapshot only -17.770
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.1% 0.2% 0.6% 0.0% 0.0% 0.0% 0.0% 2.9% 2.3% 2.8% 10.5% 5.8% 5.82%
Net Buyback Yield -0.0% -94.7% -0.0% -0.0% -0.4% -0.4% -0.2% -0.1% 0.1% 0.1% -0.2% -1.1% -9.2% -68.9% -1.9% -1.9% -75.7% -72.4% -97.5% -48.1% -48.11%
Total Shareholder Return -0.0% -94.7% -0.0% -0.0% -0.4% -0.4% -0.2% -0.1% 0.1% 0.1% -0.2% -1.1% -9.2% -68.9% -1.9% -1.9% -75.7% -72.4% -97.5% -48.1% -48.11%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.00 1.00 1.00 1.00 1.00 0.99 0.98 0.98 0.97 0.98 0.99 0.93 1.57 1.64 1.68 1.81 0.98 1.00 0.99 0.98 0.982
EBIT Margin -31.03 -15.24 -10.32 -7.64 -7.31 -7.67 -7.26 -8.42 -9.64 -9.57 -8.55 -8.551
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.04 0.05 0.07 0.06 0.06 0.06 0.06 0.06 0.06 0.08 0.080
Equity Multiplier 1.16 1.16 1.11 1.11 1.11 1.11 1.10 1.10 1.10 1.10 1.22 1.22 1.22 1.22 1.29 1.29 1.29 1.29 1.14 1.14 1.144
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-13.97 $-139300.48 $-13.09 $-12.02 $-87.16 $-50.55 $-35.91 $-36.40 $-21.18 $-16.71 $-63.69 $-39.01 $-36.48 $-21.77 $-57.45 $-22.26 $-11.11 $-11.12 $-14.57 $-10.75 $-10.75
Book Value/Share $16.72 $153086.43 $31.02 $26.81 $195.25 $102.28 $67.51 $64.56 $35.97 $28.61 $57.61 $41.75 $25.83 $16.99 $61.66 $23.55 $19.05 $15.64 $28.80 $17.88 $16.57
Tangible Book/Share $16.70 $152876.84 $31.01 $26.80 $195.14 $102.22 $67.47 $64.53 $35.95 $28.59 $51.76 $37.52 $23.21 $15.26 $61.60 $23.52 $19.03 $15.63 $28.79 $17.88 $17.88
Revenue/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.55 $4.24 $4.06 $3.05 $1.82 $4.46 $1.69 $1.34 $1.15 $1.54 $1.28 $1.28
FCF/Share $-15.23 $-141902.92 $-15.73 $-17.23 $-138.94 $-78.23 $-47.64 $-41.03 $-21.05 $-15.75 $-60.00 $-35.95 $-18.50 $-11.14 $-26.97 $-10.11 $-9.20 $-8.78 $-12.36 $-9.68 $-9.68
OCF/Share $-13.23 $-117067.94 $-10.72 $-10.49 $-78.21 $-45.92 $-31.95 $-31.14 $-17.73 $-14.08 $-55.69 $-34.29 $-17.92 $-11.05 $-26.92 $-10.11 $-8.85 $-8.39 $-11.73 $-9.16 $-9.16
Cash/Share $14.70 $134607.35 $25.34 $21.90 $159.49 $83.55 $39.18 $37.47 $20.87 $16.60 $13.62 $9.87 $6.11 $4.02 $43.64 $16.66 $13.48 $11.07 $24.40 $15.15 $13.53
EBITDA/Share $-13.98 $-139424.49 $-13.09 $-12.00 $-87.11 $-50.69 $-36.12 $-36.61 $-21.23 $-16.59 $-62.29 $-40.05 $-22.10 $-12.58 $-32.67 $-11.83 $-11.03 $-10.91 $-14.51 $-10.81 $-10.81
Debt/Share $0.25 $2289.80 $0.14 $0.12 $0.85 $0.45 $0.25 $0.24 $0.13 $0.10 $5.36 $3.88 $2.40 $1.58 $2.34 $0.89 $0.72 $0.59 $0.15 $0.10 $0.10
Net Debt/Share $-14.45 $-132317.55 $-25.21 $-21.78 $-158.63 $-83.10 $-38.93 $-37.23 $-20.74 $-16.50 $-8.26 $-5.99 $-3.70 $-2.44 $-41.30 $-15.77 $-12.76 $-10.48 $-24.24 $-15.05 $-15.05
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score -1.652
Altman Z-Prime snapshot only -2.825
Piotroski F-Score 5 6 2 3 4 3 2 2 1 2 3 3 3 4 5 4 4 5 5 6 6
Beneish M-Score 12.83 -4.47 -4.48 -2.48 -3.07 -2.20 -1.55 -1.550
Ohlson O-Score snapshot only -0.796
ROIC (Greenblatt) snapshot only -61.52%
Net-Net WC snapshot only $14.36
EVA snapshot only $-123319140.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BB
Credit Score 74.02 73.71 74.12 74.77 75.45 75.48 76.78 76.20 76.41 76.48 75.86 75.47 43.11 43.36 44.45 44.42 44.36 44.33 44.03 43.66 43.664
Credit Grade snapshot only 12
Credit Trend snapshot only -0.752
Implied Spread (bps) snapshot only 475.000
Industry Credit Rank snapshot only 39
Sector Credit Rank snapshot only 36

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms